Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06180642

Reliability and Validity of Ultrasound for the Assessment of Soft Tissue Properties After Breast Cancer Treatment

Reliability and Validity of Ultrasound for the Assessment of Structural and Mechanical Properties of Soft Tissues at the Upper Limb Region in Women After Breast Cancer Treatment

Status
Recruiting
Phase
Study type
Observational
Enrollment
90 (estimated)
Sponsor
Universiteit Antwerpen · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers

Summary

After 1 year, more than 50% experience upper limb (UL) complaints after treatment for breast cancer. These complaints are disabling and cause limitations in daily life and this leads to a decrease in the patient's quality of life. The cause of these UL complaints is complex and multifactorial. Due to breast cancer treatment, the structural (tissue composition and volume) and mechanical (tissue stiffness) properties of the soft tissue may change. These changes can occur in the muscle, skin and surrounding fascia and especially in the soft tissue around the breast and axilla where that treatment is localised. Ultrasound with specific 'add-on' techniques can objectively assess these features and provide a picture of their role in UL function after breast cancer. The first aim in this study is to investigate the reliability and validity of conventional 2D ultrasound for 1) soft tissue composition and 2) soft tissue thickness at the level of the breast and upper limb. The reliability and validity of shear wave elastography, a specific complement to conventional 2D ultrasound, to assess tissue stiffness will also be examined.

Conditions

Interventions

TypeNameDescription
OTHERAssessment of soft tissue propertiesAssessment of soft tissue properties at the upper limb region with clinical assessments and ultrasound
OTHERRetest assessment of soft tissue propertiesRetest Assessment of soft tissue properties at the upper limb region with clinical assessments and ultrasound

Timeline

Start date
2023-05-02
Primary completion
2025-05-02
Completion
2026-05-02
First posted
2023-12-22
Last updated
2024-12-11

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT06180642. Inclusion in this directory is not an endorsement.